C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 84 filers reported holding C4 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $132,000 | -76.9% | 71,163 | -65.7% | 0.00% | -50.0% |
| Q2 2023 | $571,000 | -7.8% | 207,456 | +5.3% | 0.00% | -33.3% |
| Q1 2023 | $619,000 | -46.8% | 197,045 | 0.0% | 0.00% | -40.0% |
| Q4 2022 | $1,163,000 | -42.8% | 197,045 | -15.1% | 0.01% | -44.4% |
| Q3 2022 | $2,034,000 | +18.5% | 231,966 | +1.9% | 0.01% | +28.6% |
| Q2 2022 | $1,717,000 | +47.5% | 227,725 | +374.6% | 0.01% | +75.0% |
| Q1 2022 | $1,164,000 | -2.6% | 47,985 | +29.3% | 0.00% | 0.0% |
| Q4 2021 | $1,195,000 | -28.0% | 37,122 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $1,659,000 | +18.1% | 37,122 | 0.0% | 0.01% | +20.0% |
| Q2 2021 | $1,405,000 | +2.3% | 37,122 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $1,373,000 | – | 37,122 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $21,495,000 | 5.67% |
| Soleus Capital Management, L.P. | 750,633 | $33,538,000 | 5.23% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $73,374,000 | 4.55% |
| RTW INVESTMENTS, LP | 2,494,965 | $111,475,000 | 1.68% |
| P.A.W. CAPITAL CORP | 40,000 | $1,787,000 | 1.59% |
| Perceptive Advisors | 2,258,566 | $100,913,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 381,774 | $17,058,000 | 1.43% |
| CLOUGH CAPITAL PARTNERS L P | 347,500 | $15,526,000 | 0.94% |
| HighVista Strategies LLC | 29,341 | $1,311,000 | 0.87% |
| RA Capital Management | 1,377,569 | $61,550,000 | 0.85% |